Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease

Clinical trial NCT01442025 · COMPLETED

Trial details

NCT number: NCT01442025
Sponsor: Groupe d'Etude Therapeutique des Affections Inflammatoires Digestives
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Crohn's Disease

Start date: 2012-06-01
Primary completion: 2015-07-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.